Send mail to Author

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____    __   __    ______    ______    ____     __   __  
 |__  //   \ \\/ //  /_   _//  /_   _//  |  _ \\   \ \\/ // 
   / //     \ ` //   `-| |,-    -| ||-   | |_| ||   \ ` //  
  / //__     | ||      | ||     _| ||_   | .  //     | ||   
 /_____||    |_||      |_||    /_____//  |_|\_\\     |_||   
 `-----`     `-`'      `-`'    `-----`   `-` --`     `-`'
 


Back to frontdoor view

OPUS4 Logo